Northern Virginia, Washington D.C., Suburban Maryland
NOVA CFS / ME, FM, & OI Support Group
Click here for more events: www.geocities.com/cfsnova/events.html
Contact: Elly Brosius: #703-968-9818
Toni Marshall: #410-647-7578
E-mail: cfsupport-ower@yahoogroups.com
Sign up for Email: groups.yahoo.com/group/CFSupport
In The News
04.25.2009
Paul Cheney, MD, PhD will speak on: CFS: Is Oxygen the Problem and Why? A Four-Part Treatment Protocol. In addition to a broad overview of Chronic Fatigue Syndrome including case definition, clinical findings, and key medical literature, Dr. Cheney will present on oxygen toxicity in CFS as well as his latest four-part treatment protocol.
Where: Fairfax County Government Center, Board Auditorium
12000 Government Center Parkway
Fairfax VA 22035
When: Saturday, April 25st
Time: 6:00 - 9:00 p.m.
Price: FREE - Registration required
Please refrain from wearing scented products.
Oxygen Toxicity as a Controlling Factor for CFS
This section of the presentation will focus on the research finding of nearly 100% toxicity in CFS patients when oxygen is administered. Dr. Cheney will present evidence that patients categorized according to increasingly powerful treatment protocols were transformed to an increasingly oxygen tolerant state. The most powerful treatment protocol was also associated with significant overall clinical improvement. Conclusions drawn from this are CFS is an oxygen toxic state, oxygen toxicity status appears to determine outcome in therapeutic trials, and oxygen toxicity is key to this illness. These findings appear to force a narrowing of potential causes of CFS because whatever pathophysiology one puts forth must explain universal oxygen toxicity in CFS. Dr. Cheney will also present recent evidence
of the likely cause of this oxygen toxicity.
Cell Associated Therapy for Chronic Fatigue Syndrome: Is this the Next Frontier?
Dr. Cheney will discuss the use of low molecular weight (LMW), mammalian tissue derived peptides as therapeutic agents when applied to the skin using novel transdermal gels. These LMW peptides are known to control gene expression and can shift organ function toward normal. Data will be presented from a one-year prospective trial in CFS using these LMW peptides which produced significant improvement in function. Therapy with LMW peptides from cell associated, mammalian tissue homogenates appear to offer a significant benefit in CFS,
especially where it counts the most, namely, the functioning of the patient.
Questions?
Elly Brosius: #703-968-9818
E-mail: cfsupport-ower@yahoogroups.com
Event co-sponsored & videoed/recorded by: The CFS & FM Support Group of Dallas/ Fort Worth, TX Click: www.DFWCFIDS.org
____
03.21.2009
Dr. Peter Rowe, Professor of the Chronic Fatigue & Related Disorders Department of Pediatrics, John Hopkins University School of Medicine & Director of the Chronic Fatigue Clinic at John Hopkins Children's Center will speak on: “Update on Orthostatic Intolerance in CFS."
Dr. Rowe will describe the links between disturbances in the control of blood pressure and heart rate in those with Chronic Fatigue Syndrome (CFS), and will discuss practical aspects of managing symptoms
caused by the circulatory problems.
Where: Sully Governmental Center
James McDonnell Room
4900 Stonecroft Blvd
Chantilly VA 20151
(New 2009 monthly location is the same building as Sully District Police
Station)
When: Saturday, March 21st
Time: 2:00-4:30 p.m.
Contact: Elly Brosius from the NOVA CFS/ME Support Group for questions: #703- 968-9818 or Toni Marshall #410-647-7578
E-Mail Elly & Toni: cfsupport-ower@yahoogroups.com
Look up more events: www.geocities.com/cfsnova/events.html
Sign up for Email: groups.yahoo.com/group/CFSupport
__
|
